Saturday, 31 October 2026European Markets

CENERGY Stock Was Up By 9.07% On Tuesday

Loading stream...

(VIANEWS) - The Market ended the session with CENERGY (CENER.BR) jumping 9.07% to €5.77 on Tuesday, after five successive sessions in a row of losses. BEL 20 jumped 1.75% to €3,540.94, following the last session's downward trend on what was an all-around up trend trading session today.

About CENERGY

Cenergy Holdings SA manufactures and sells aluminum, copper, cables, steel and steel pipes, and other related products in Belgium and internationally. It operates through two segments: Cables and Steel Pipes. The company offers submarine and land, power distribution, high voltage direct current, wind farm, industrial, signalling and railway signalling, network, data transmission, telecommunication, umbilicals, and optical fiber cables, as well as low, medium, high, and extra high voltage power cables; and fiber to the home cables. It also provides turnkey solutions, such as custom adapted application, supervision, technical support, transport and storage, training, spare part, installation, and repair and replacement. In addition, the company offers onshore and offshore pipelines, and casing pipes for transportation of oil, gas, and hydrogen, as well as carbon capture and storage applications; and hollow structural section products which are primarily used in the construction, power and telecom cables, wires, and raw materials. It serves power grids, interconnections, offshore and onshore wind, solar energy, telecommunications and data transmission, oil and gas, and heavy industries. The company was founded in 1949 and is based in Brussels, Belgium. Cenergy Holdings SA operates as a subsidiary of Viohalco S.A.

Earnings Per Share

As for profitability, CENERGY has a trailing twelve months EPS of €0.3.

PE Ratio

CENERGY has a trailing twelve months price to earnings ratio of 19.23. Meaning, the purchaser of the share is investing €19.23 for every euro of annual earnings.

More news about CENERGY (CENER.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com